Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-06-28 | New | $3,898,385 | $3,898,385 | Debt Only | 06b | SEC link |
| 2022-12-05 | Amended | $7,988,250 | $4,763,250 | Equity Only | 06b | SEC link |
| 2022-03-01 | New | $3,225,000 | $3,225,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Michael Berendt | Director |
| Eric Keller | Director, Executive |
| Donald Olds | Director |
| Paul Sweetnam | Executive |